Dixon Hubard Feinour & Brown’s Medtronic MDT Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.18M	Buy	13,181 +12	+0.1%	+$1.22K	0.14%	135
2022 Q1	$1.46M	Sell	13,169 -296	-2%	-$31.3K	0.15%	141
2021 Q4	$1.39M	Buy	13,465 +11,710	+667%	+$1.36M	0.13%	137
2021 Q3	$220K	Hold	1,755	–	–	0.05%	172
2021 Q2	$218K	Sell	1,755 -2,543	-59%	-$319K	0.05%	175
2021 Q1	$447K	Hold	4,298	–	–	0.06%	158
2020 Q4	$447K	Hold	4,298	–	–	0.11%	108
2020 Q3	$447K	Sell	4,298 -40	-0.9%	-$4.02K	0.11%	108
2020 Q2	$418K	Sell	4,338 -884	-17%	-$84.8K	0.11%	111
2020 Q1	$471K	Buy	5,222 +630	+14%	+$67K	0.16%	100
2019 Q4	$521K	Buy	4,592 +195	+4%	+$21.4K	0.14%	109
2019 Q3	$478K	Buy	4,397 +1,375	+45%	+$143K	0.13%	110
2019 Q2	$294K	Hold	3,022	–	–	0.08%	140
2019 Q1	$275K	Buy	3,022 +22	+0.7%	+$1.97K	0.08%	142
2018 Q4	$273K	Hold	3,000	–	–	0.1%	126
2018 Q3	$295K	Hold	3,000	–	–	0.08%	138
2018 Q2	$257K	Hold	3,000	–	–	0.07%	141
2018 Q1	$241K	Hold	3,000	–	–	0.07%	165
2017 Q4	$242K	Buy	+3,000	New	+$240K	0.07%	165

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dixon Hubard Feinour & Brown's MDT Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown increased its Medtronic (MDT) stake by 0.09% in Q2 2022, buying an estimated $1.22K and bringing the position to 13,181 shares worth $1.18M. The position accounts for 0.14% of the portfolio, ranked #135.

Dixon Hubard Feinour & Brown first reported a position in MDT in Q4 2017 and has held it in 19 quarters since. The position peaked at $1.46M in Q1 2022. 2,021 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

Dixon Hubard Feinour & Brown held 13,181 shares of Medtronic worth $1.18M as of Q2 2022.
Dixon Hubard Feinour & Brown bought 12 Medtronic shares in Q2 2022, an estimated $1.22K.
Medtronic made up 0.14% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #135 holding.
Dixon Hubard Feinour & Brown first reported a position in Medtronic in Q4 2017 and has held it in 19 quarters since.
Dixon Hubard Feinour & Brown's Medtronic position peaked at $1.46M in Q1 2022.
2,021 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.